Summit Therapeutics Inc. - Balance Sheet (Quarterly)

Summit Therapeutics Inc.
MX ˙ BMV ˙ US86627T1088
Balance Sheet (Quarterly)

Summit Therapeutics Inc. Balance Sheet shows account balances for the company at points in time. Balance Sheet data includes Assets, Current Assets, Fixed Assets, Property, Plant and Equipment (PPE), Inventory, Intangibles, Liabilities, Current Liabilities, Debt, Capital Lease Obligations, Common Stock, Retained Earnings, Treasury Stock, and Shareholders Equity.

All numbers are times 1,000,000.00 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 21 66 102 103 80 72 77 57 122 349 71 42 24 71 61 28 94 105 212 298
Change (%) 212.26 53.87 1.17 -22.38 -10.54 7.88 -25.97 112.73 185.81 -79.64 -40.66 -43.51 200.21 -14.18 -53.61 229.80 11.82 101.72 40.82
Assets Current 42 88 125 121 102 97 99 79 137 657 248 228 205 190 163 329 490 424 371 309
Change (%) 108.37 42.82 -2.98 -15.86 -4.79 2.18 -20.15 72.70 378.94 -62.23 -8.28 -9.91 -7.44 -13.94 101.39 49.12 -13.57 -12.51 -16.59
Assets 57 102 141 146 129 113 116 96 155 664 255 237 218 203 177 342 503 436 384 324
Change (%) 80.25 37.36 3.35 -11.58 -11.89 2.73 -17.82 62.28 327.59 -61.62 -6.88 -7.96 -7.11 -12.89 93.38 47.09 -13.38 -11.88 -15.58
Liabilities 20 23 76 26 26 30 52 44 22 538 121 118 119 125 133 147 65 47 39 65
Change (%) 15.20 231.48 -65.85 1.09 14.09 73.03 -14.72 -50.27 2,334.50 -77.41 -3.00 1.12 5.17 5.84 10.72 -55.76 -27.91 -15.64 63.57
Equity 37 79 64 119 102 83 64 51 133 127 133 120 99 78 44 195 438 389 344 259
Change (%) 115.55 -18.94 85.43 -14.34 -18.59 -22.67 -20.32 159.66 -4.95 5.39 -10.40 -16.91 -21.82 -43.10 341.25 124.49 -11.23 -11.43 -24.65
Liabilities And Stock Equity 57 102 141 146 129 113 116 96 155 664 255 237 218 203 177 342 503 436 384 324
Change (%) 80.25 37.36 3.35 -11.58 -11.89 2.73 -17.82 62.28 327.59 -61.62 -6.88 -7.96 -7.11 -12.89 93.38 47.09 -13.38 -11.88 -15.58

Source: Capital IQ

Other Listings
US:SMMT $25.98
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista